Financial Professionals and Clients Disagree on Key Retirement Planning Conversations

New Alliance for Lifetime Income by LIMRA findings suggest this disconnect undermines retirement readiness Financial professionals (FPs) and their clients have sharply different views on whether they discuss critical health-related issues during retirement planning, according to the final chapter of Alliance for Lifetime Income by LIMRA's 2025 Protected Lifetime Income & Planning (PRIP) study released […]

1 million strong: How CompTIA Security+ shapes cybersecurity skills around the world

Certification validates the skills required for core security functions and careers in cybersecurity More than one million individuals worldwide have earned the CompTIA Security+ certification, CompTIA, the leading global provider of vendor-neutral information technology (IT) training and certifications, announced today. https://mma.prnewswire.com/media/2608749/CompTIA_Logo_Logo.jpg The milestone underscores the vital role CompTIA Security+ holds in validating foundational cybersecurity skills

Lennar Confirms Expiration Date of Exchange Offer

Expects Registration Statement to be Effective by Expiration Date Lennar Corporation (NYSE: LEN and LEN.B) (“Lennar”) confirmed today that in view of the reopening of the U.S. federal government, Lennar is proceeding as previously announced with the offer to exchange the approximately 20% of the total outstanding shares of Millrose Properties, Inc. (NYSE: MRP) (“Millrose”)

Jacobs to Lead Terminal Modernization at Ohio’s Busiest Airport

Cleveland Hopkins International Airport upgrades to improve critical infrastructure Jacobs (NYSE: J) has been selected to lead program and construction management services for phase one of a $1.6 billion modernization of Cleveland Hopkins International Airport (CLE). The transformative program, CLEvolution, is designed to reimagine the airport experience for millions of travelers by modernizing aging infrastructure

Kikoff Integrates Optimal Path™ Interactive Score Planner from Equifax

Kikoff's One Million-Plus Members will be Equipped to Achieve their Personalized Credit Score Goals and Advance their Financial Health Equifax® (NYSE: EFX) and Kikoff, a personal finance platform that expands access to credit and financial services, today announced that Optimal Path™, the interactive score planner introduced by Equifax earlier this year, will be integrated into

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESS Newswire / November 18, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in DexCom, Inc. ("DexCom") (NASDAQ:DXCM) who purchased or otherwise acquired DexCom securities between January 8, 2024 and September 17, 2025, inclusive (the "Class Period") to contact us immediately regarding the pending securities

New SueWallSt Podcast Covers James Hardie Industries plc. (JHX) Class Action

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding James Hardie Industries plc. (NYSE:JHX) class action securities lawsuit A Class Action lawsuit was filed on behalf of James Hardie Industries plc. investors who lost money as a result of alleged securities fraud between May 20,

Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights

(NASDAQ:RPTX),(NYSE:SEE), NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Repare Therapeutics Inc. (NASDAQ: RPTX)'s sale to XenoTherapeutics, Inc. Upon closing of the proposed transaction, it

Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR

(NASDAQ:JSPR), LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Scroll to Top